Bioxyne Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Bioxyne Limited with three other companies in this sector in AUSTRALIA : Oncosil Medical Ltd (2020 sales of 2.96 million Australian Dollars [US$2.08 million] of which 100% was Medical Treatments), Lbt Innovations Limited (1.75 million Australian Dollars [US$1.23 million] of which 100% was ommercialising innovative technologie), and Proteomics International Laboratories Ltd (1.61 million Australian Dollars [US$1.14 million] of which 100% was single business).

Sales Analysis. During the year ended June of 2020, sales at Bioxyne Limited were A$2.26 million (US$1.59 million). This is an increase of 5.9% versus 2019, when the company's sales were A$2.13 million. This was the third consecutive year of growth at Bioxyne Limited.